The Contrast Enhanced Ultrasound Market was valued at USD 2.14 billion in 2024, and is projected to reach USD 2.99 billion by 2030, rising at a CAGR of 5.80%. The increasing prevalence of chronic diseases such as cancer, cardiovascular, and liver disorders drives the demand for accurate and early diagnosis. Patients and clinicians increasingly favor noninvasive procedures like Contrast Enhanced Ultrasound (CEUS) due to their safety, speed, and lack of radiation exposure. This growing preference and the need for ongoing disease monitoring fuel rapid adoption of CEUS technologies across global healthcare systems, thereby expanding market size and clinical utilization.
Global investments in healthcare infrastructure fuel the adoption of advanced diagnostic tools like CEUS. Modern hospitals and diagnostic centers are increasingly equipping themselves with CEUS systems to improve patient care. In addition, an aging population contributes to a surge in chronic conditions that require regular imaging. These demographic and infrastructure trends are significantly increasing the demand for CEUS, making it a vital component of modern diagnostic strategies worldwide.
Ongoing innovations in ultrasound technology and contrast agent development enhance the accuracy, efficiency, and safety of CEUS. These improvements have broadened CEUS applications across multiple medical fields, including oncology, cardiology, and nephrology. The ability to use CEUS for real-time, detailed imaging in various organs supports faster, more informed clinical decisions. This expansion into diverse diagnostic areas is expected to drive widespread adoption and boost market growth over the coming years.
This product will be delivered within 1-3 business days.
Global investments in healthcare infrastructure fuel the adoption of advanced diagnostic tools like CEUS. Modern hospitals and diagnostic centers are increasingly equipping themselves with CEUS systems to improve patient care. In addition, an aging population contributes to a surge in chronic conditions that require regular imaging. These demographic and infrastructure trends are significantly increasing the demand for CEUS, making it a vital component of modern diagnostic strategies worldwide.
Ongoing innovations in ultrasound technology and contrast agent development enhance the accuracy, efficiency, and safety of CEUS. These improvements have broadened CEUS applications across multiple medical fields, including oncology, cardiology, and nephrology. The ability to use CEUS for real-time, detailed imaging in various organs supports faster, more informed clinical decisions. This expansion into diverse diagnostic areas is expected to drive widespread adoption and boost market growth over the coming years.
Contrast Enhanced Ultrasound Market Report Highlights
- By product, the equipment segment held the largest share of 71.7% in 2024 due to the rising adoption of advanced ultrasound systems and increasing demand for precise diagnostic tools.
- The contrast agents segment is anticipated to be the fastest-growing segment from 2025 to 2030,fueled bythe rising prevalence of chronic diseases and growing awareness of noninvasive diagnostic procedures.
- By type, the non-targeted segment led the market with the largest revenue share in 2024, attributed to its broad clinical applicability and ease of use.
- By end use, the hospitals segment dominated the market with the largest share in 2024, owing to high patient volumes, access to advanced imaging technologies, and the availability of skilled professionals.
- North America accounted for the largest revenue share of 34.6% in 2024, propelled bya well-established healthcare infrastructure, widespread adoption of advanced imaging technologies, and favorable reimbursement policies for CEUS procedures.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Contrast Enhanced Ultrasound Market Variables, Trends, & Scope
Chapter 4. Contrast Enhanced Ultrasound Market: Product Estimates & Trend Analysis
Chapter 5. Contrast Enhanced Ultrasound Market: Type Estimates & Trend Analysis
Chapter 6. Contrast Enhanced Ultrasound Market: End Use Estimates & Trend Analysis
Chapter 7. Contrast Enhanced Ultrasound Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies featured in this Contrast Enhanced Ultrasound market report include:- Lantheus Medical Imaging, Inc.
- GE Healthcare
- Bracco
- GE HealthCare
- Siemens Healthcare GmbH
- Koninklijke Philips N.V.
- CANON MEDICAL SYSTEMS CORPORATION
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 130 |
Published | May 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 2.14 Billion |
Forecasted Market Value ( USD | $ 2.99 Billion |
Compound Annual Growth Rate | 5.8% |
Regions Covered | Global |
No. of Companies Mentioned | 9 |